道琼斯指数
52,475.1
涨跌
+97.53+0.19%
在 MEXC 探索美国生物科技板块股票,涵盖专注于药物研发、基因治疗及生物学研究的公司。比较股价、当日涨跌、市值和成交量,全面了解生物科技行业动态。

今日美股市场走势分化,道琼斯指数涨跌幅为 +0.19%,标普 500 指数为 +0.28%,纳斯达克综合指数为 +0.27%。个股方面,2,381 只上涨、2,738 只下跌,市场整体呈现分化格局。
| # | 股票 | 52 周价格区间 | |||||
|---|---|---|---|---|---|---|---|
| 51 | Ginkgo Bioworks Holdings, Inc.DNA | $13.17 | +15.57% | 1.62M | $729.52M | $5.37 - $18.22 | 0.00% |
| 52 | Solid Biosciences Inc.SLDB | $6.29 | +2.10% | 291.86K | $673.91M | $3.79 - $11.45 | 0.00% |
| 53 | 4D Molecular Therapeutics, Inc.FDMT | $12.11 | +1.51% | 233.11K | $669.01M | $6.96 - $16.93 | 0.00% |
| 54 | DBV Technologies S.A.DBVT | $10.63 | +4.54% | 68.53K | $668.33M | $8.63 - $26.18 | 0.00% |
| 55 | Candel Therapeutics, Inc.CADL | $8.51 | +3.52% | 234.82K | $650.79M | $4.35 - $14.00 | 0.00% |
| 56 | Aura Biosciences, Inc.AURA | $6.26 | -0.24% | 111.89K | $649.71M | $4.73 - $9.54 | 0.00% |
| 57 | Attovia Therapeutics, Inc.ATTO | $15.11 | +2.00% | 44.46K | $631.36M | $12.94 - $28.00 | 0.00% |
| 58 | Entera Bio Ltd.ENTX | $3.10 | +0.33% | 20.06K | $540.03M | $0.91 - $4.20 | 0.00% |
| 59 | NRC HealthNRC | $22.81 | +3.59% | 89.89K | $514.15M | $11.43 - $23.71 | 0.03% |
| 60 | Allogene Therapeutics, Inc.ALLO | $1.30 | +6.50% | 4.59M | $450.87M | $1.04 - $4.46 | 0.00% |
| 61 | REGENXBIO Inc.RGNX | $6.81 | +2.58% | 424.66K | $449.55M | $5.46 - $16.19 | 0.00% |
| 62 | C4 Therapeutics, Inc.CCCC | $3.50 | +7.94% | 1.46M | $430.22M | $1.69 - $5.17 | 0.00% |
| 63 | Editas Medicine, Inc.EDIT | $2.77 | +6.35% | 1.65M | $425.42M | $1.66 - $3.94 | 0.00% |
| 64 | Zura Bio LimitedZURA | $4.23 | 0.00% | 2.49M | $405.36M | $3.25 - $7.44 | 0.00% |
| 65 | Tectonic Therapeutic, Inc.TECX | $20.53 | +1.03% | 57.96K | $401.33M | $15.52 - $39.53 | 0.00% |
| 66 | Eikon Therapeutics, Inc.EIKN | $5.60 | +2.02% | 217.31K | $393.24M | $5.33 - $17.40 | 0.00% |
| 67 | Fennec Pharmaceuticals Inc.FENC | $10.54 | -0.76% | 21.39K | $370.32M | $5.65 - $13.25 | 0.00% |
| 68 | Kyverna Therapeutics, Inc.KYTX | $5.88 | +4.80% | 278.60K | $363.39M | $5.16 - $13.67 | 0.00% |
| 69 | Surrozen, Inc.SRZN | $30.20 | +2.13% | 44.40K | $350.62M | $11.39 - $37.83 | 0.00% |
| 70 | IRulya Therapeutics Inc.IRLA | $31.45 | -2.71% | 31.71K | $340.91M | $25.13 - $41.00 | 0.00% |
| 71 | X4 Pharmaceuticals, Inc.XFOR | $3.27 | +0.92% | 113.54K | $324.71M | $2.43 - $4.83 | 0.00% |
| 72 | ProKidney Corp.PROK | $1.51 | +0.66% | 639.57K | $316.52M | $1.30 - $3.27 | 0.00% |
| 73 | Agenus Inc.AGEN | $6.89 | +3.46% | 165.09K | $311.17M | $2.71 - $10.31 | 0.00% |
| 74 | Scribe Therapeutics Inc.SCTX | $16.01 | +0.63% | 84.00K | $291.64M | $13.50 - $39.60 | 0.00% |
| 75 | SAB Biotherapeutics, Inc.SABS | $3.15 | +1.63% | 59.37K | $286.52M | $2.44 - $5.15 | 0.00% |
| 76 | Century Therapeutics, Inc.IPSC | $1.46 | +0.34% | 171.12K | $263.46M | $0.43 - $3.04 | 0.00% |
| 77 | Ocugen, Inc.OCGN | $0.76 | +0.51% | 2.78M | $256.37M | $0.70 - $2.73 | 0.00% |
| 78 | Cabaletta Bio, Inc.CABA | $1.48 | +1.72% | 1.83M | $251.10M | $1.32 - $4.23 | 0.00% |
| 79 | Fate Therapeutics, Inc.FATE | $2.10 | +1.45% | 357.43K | $251.02M | $0.95 - $3.23 | 0.00% |
| 80 | Alector, Inc.ALEC | $2.17 | +3.10% | 875.84K | $241.74M | $1.09 - $2.76 | 0.00% |
| 81 | Lexeo Therapeutics, Inc.LXEO | $2.91 | +2.09% | 339.03K | $238.43M | $2.55 - $10.99 | 0.00% |
| 82 | Inhibikase Therapeutics, Inc.IKT | $1.59 | +1.27% | 65.84K | $222.56M | $1.33 - $2.61 | 0.00% |
| 83 | Artiva Biotherapeutics, Inc.ARTV | $4.29 | +0.59% | 1.18M | $209.74M | $2.96 - $14.53 | 0.00% |
| 84 | Palisade Bio, Inc.PALI | $1.16 | -3.75% | 6.73M | $201.28M | $1.15 - $2.85 | 0.00% |
| 85 | Alpha Cognition Inc.ACOG | $9.02 | +0.95% | 38.24K | $196.33M | $4.50 - $10.14 | 0.00% |
| 86 | Precision BioSciences, Inc.DTIL | $7.08 | +3.53% | 52.58K | $195.56M | $3.53 - $9.62 | 0.00% |
| 87 | Invivyd, Inc.IVVD | $0.61 | +4.81% | 1.37M | $180.69M | $0.53 - $3.07 | 0.00% |
| 88 | Coherus Oncology, Inc.CHRS | $1.16 | +7.94% | 697.22K | $178.45M | $0.94 - $2.62 | 0.00% |
| 89 | MaxCyte, Inc.MXCT | $1.70 | +10.06% | 734.37K | $174.93M | $0.64 - $1.80 | 0.00% |
| 90 | Acumen Pharmaceuticals, Inc.ABOS | $2.36 | +4.87% | 552.35K | $170.38M | $1.50 - $3.60 | 0.00% |
| 91 | Sutro Biopharma, Inc.STRO | $8.89 | +0.62% | 135.65K | $147.36M | $7.15 - $43.85 | 0.00% |
| 92 | Protara Therapeutics, Inc.TARA | $2.38 | -3.85% | 253.81K | $140.35M | $2.28 - $7.82 | 0.00% |
| 93 | Compass Therapeutics, Inc.CMPX | $0.74 | -1.45% | 444.54K | $133.63M | $0.73 - $6.88 | 0.00% |
| 94 | Outlook Therapeutics, Inc.OTLK | $0.54 | +1.32% | 501.68K | $131.71M | $0.16 - $2.54 | 0.00% |
| 95 | Humacyte, Inc.HUMA | $0.47 | +7.30% | 1.53M | $131.12M | $0.34 - $1.78 | 0.00% |
| 96 | Anavex Life SciencesAVXL | $1.25 | -4.58% | 234.11K | $116.33M | $1.14 - $8.45 | 0.00% |
| 97 | Voyager Therapeutics, Inc.VYGR | $1.74 | +0.58% | 419.95K | $106.91M | $1.71 - $5.48 | 0.00% |
| 98 | enGene Therapeutics Inc.ENGN | $1.56 | -0.32% | 610.98K | $104.88M | $1.40 - $12.25 | 0.00% |
| 99 | Tevogen Inc.TVGN | $6.56 | +2.15% | 10.82K | $103.20M | $3.64 - $32.50 | 0.00% |
| 100 | Black Diamond Therapeutics, Inc.BDTX | $1.79 | +2.00% | 424.08K | $103.13M | $1.60 - $4.94 | 0.00% |
| 现货美股(RealStocks) | 代币化美股(Tokenized Stocks) | 股票合约(Stock Futures) | |
|---|---|---|---|
| 是什么 | 美股上市公司的真实股份(现货美股) | 与美股/ETF 挂钩的区块链代币 | 以 USDT 保证金进行的股价合约交易 |
| 所有权 | 是 —— 真实持股 | 否 —— 仅为合成敞口 | 否 —— 仅为衍生品敞口 |
| 股东权益 | 有(如分红) | 无 | 无 |
| 交易时间 | 美股交易时段(盘前、正常、盘后、隔夜) | 24/7 全天候 | 支持交易对最高可达 24/7 全天候 |
| 持仓方式 | 买入并持有 | 买入并持有 | 支持多空双向、杠杆交易 |
| 适合人群 | 追求长期持有和分红收益的投资者 | 希望全天候获得股票敞口、无需持有股票的交易者 | 希望通过杠杆进行投机或对冲的短线/活跃交易者 |
通过 MEXC 合作的持牌券商购买真实美股,并可按适用条件享有股息等股东权益。
覆盖 7,000+ 只美国上市股票及 ETF,涵盖科技、金融、医疗、消费等多个行业。
支持 USDT 转入及 USDT/USD 转换,更便捷地为 RealStocks 账户提供资金。
以具有竞争力的交易成本参与真实美股交易,让更多资金用于投资策略。
本页面展示的美股价格、指数、排行榜、图表及其他市场数据可能来自第三方数据提供商,并可能存在延迟或误差。MEXC 提供的相关信息仅供参考和教育用途,不对其准确性或完整性作出保证。页面内容不构成任何金融或投资建议,也不构成买卖任何证券的推荐。美股交易存在风险,历史表现不代表未来结果,用户应在作出投资决定前进行独立研究。